Evidence map›Paper›PMID 38009133›Full record

ArticleHarvard data science review2022

Personalized Data Science and Personalized (N-of-1) Trials: Promising Paradigms for Individualized Health Care.

Naihua Duan, Daniel Norman, Christopher Schmid, Ida Sim, Richard L Kravitz

Abstract read
In one paragraph

Article in Harvard data science review, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exploring human biology with N-of-1 clinical trials.Cambridge prisms. Precision medicine · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Naihua DuanDepartment of Psychiatry, Columbia University, New York, NY).
Daniel NormanSanta Monica Sleep Disorders Center, Los Angeles, CA.
Christopher SchmidBrown University, Providence, RI.
Ida SimDepartment of Medicine, University of California San Francisco, San Francisco, CA.
Richard L KravitzUniversity of California, Davis, Davis, CA.

Funding

Re-engineering Precision Therapeutics Through N-of-1 TrialsR01LM012836 · NLM · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI DAVIDSON, KARINA W. · 2017 to 2023
$7.6M
Roybal Center for Personalized Trials: Physical Activity Promotion to Foster Healthy AgingP30AG063786 · NIA · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI Karina W. Davidson · 2020 to 2026
$6.7M
NIA NIH HHS P30 AG063786NLM NIH HHS R01 LM012836
6 · The paper itself

Abstract

The term 'data science' usually refers to the process of extracting value from

Indexed as

case-crossover designheterogeneity of treatment effectsmonitoringpre-post trialsself-trackingsymptom triggers

Identifiers

PMID38009133
PMCPMC10673628

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.